[{"edinetCode":"E02991","endDate":"2017\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":125.0,"averageTemporaryStaff":39.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2471600.0,"sharesOwendPercent":0.4087,"outstandingShares":null,"numberOfSubsidiary":1.0,"bps":1076.35,"equityRatio":0.785,"cashAndCashEquivalents":1383000000.0,"assets":8126000000.0,"currentAssets":5143000000.0,"fixedAsset":2982000000.0,"tangibleFixedAssets":690000000.0,"intangibleFixedAssets":249000000.0,"investmentAndOtherAssets":2041000000.0,"liabilities":1288000000.0,"currentLiabilities":799000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":488000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":6838000000.0,"capitalStock":5914000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":3812000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":466000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":7068000000.0,"costOfSales":4535000000.0,"grossProfit":2532000000.0,"sgaExpenses":2339000000.0,"salaryAndBenefit":589000000.0,"depreciationAndSGA":null,"RDExpenses":96000000.0,"operatingIncome":193000000.0,"nonOperatingIncome":208000000.0,"nonOperatingExpenses":3000000.0,"interestExpense":0.0,"ordinaryProfit":397000000.0,"extraordinaryGain":8000000.0,"extraordinaryLoss":5000000.0,"incomeBeforeTax":400000000.0,"incomeTaxes":149000000.0,"netIncome":250000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":237000000.0,"comprehensiveIncome":365000000.0,"eps":40.15,"dilutedEps":null,"dividendPerShare":null,"per":27.9,"roe":0.038,"cashFlowFromOperatingActivities":89000000.0,"depreciationAndCashflowFromOperatingActivities":156000000.0,"cashFlowFromInvestingActivities":-235000000.0,"cashFlowFromFinancialActivities":-109000000.0,"changesInCashAndCashEquivalents":-264000000.0,"列1":"asr","submitDate":"2018\/3\/26","stockCode":3386,"accountingYear":"第35期（自　平成29年１月１日　至　平成29年12月31日）","accountingYearStart":"2017\/1\/1","accountingYearEnd":"2017\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2018\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":125.0,"averageTemporaryStaff":44.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2474000.0,"sharesOwendPercent":0.4174,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1110.06,"equityRatio":0.774,"cashAndCashEquivalents":2068000000.0,"assets":8501000000.0,"currentAssets":5668000000.0,"fixedAsset":2832000000.0,"tangibleFixedAssets":636000000.0,"intangibleFixedAssets":252000000.0,"investmentAndOtherAssets":1943000000.0,"liabilities":1448000000.0,"currentLiabilities":945000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":502000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7053000000.0,"capitalStock":6128000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4026000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":451000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":7261000000.0,"costOfSales":4602000000.0,"grossProfit":2659000000.0,"sgaExpenses":2330000000.0,"salaryAndBenefit":642000000.0,"depreciationAndSGA":null,"RDExpenses":70000000.0,"operatingIncome":328000000.0,"nonOperatingIncome":89000000.0,"nonOperatingExpenses":13000000.0,"interestExpense":0.0,"ordinaryProfit":403000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":403000000.0,"incomeTaxes":125000000.0,"netIncome":278000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":260000000.0,"comprehensiveIncome":259000000.0,"eps":43.93,"dilutedEps":null,"dividendPerShare":null,"per":20.0,"roe":0.04,"cashFlowFromOperatingActivities":908000000.0,"depreciationAndCashflowFromOperatingActivities":178000000.0,"cashFlowFromInvestingActivities":-185000000.0,"cashFlowFromFinancialActivities":-85000000.0,"changesInCashAndCashEquivalents":636000000.0,"列1":"asr","submitDate":"2019\/3\/27","stockCode":3386,"accountingYear":"第36期（自　平成30年１月１日　至　平成30年12月31日）","accountingYearStart":"2018\/1\/1","accountingYearEnd":"2018\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2019\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.771,"cashAndCashEquivalents":null,"assets":8791000000.0,"currentAssets":5841000000.0,"fixedAsset":2950000000.0,"tangibleFixedAssets":630000000.0,"intangibleFixedAssets":234000000.0,"investmentAndOtherAssets":2084000000.0,"liabilities":1540000000.0,"currentLiabilities":1001000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":538000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7251000000.0,"capitalStock":6229000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4127000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":544000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2148000000.0,"costOfSales":1338000000.0,"grossProfit":809000000.0,"sgaExpenses":583000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":226000000.0,"nonOperatingIncome":4000000.0,"nonOperatingExpenses":3000000.0,"interestExpense":0.0,"ordinaryProfit":227000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":227000000.0,"incomeTaxes":72000000.0,"netIncome":154000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":147000000.0,"comprehensiveIncome":248000000.0,"eps":24.94,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/5\/13","stockCode":3386,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2019\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2483400.0,"sharesOwendPercent":0.4189,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.772,"cashAndCashEquivalents":2222000000.0,"assets":8668000000.0,"currentAssets":5620000000.0,"fixedAsset":3047000000.0,"tangibleFixedAssets":732000000.0,"intangibleFixedAssets":228000000.0,"investmentAndOtherAssets":2086000000.0,"liabilities":1497000000.0,"currentLiabilities":964000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":533000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7170000000.0,"capitalStock":6261000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4159000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":434000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":3794000000.0,"costOfSales":2332000000.0,"grossProfit":1461000000.0,"sgaExpenses":1220000000.0,"salaryAndBenefit":330000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":241000000.0,"nonOperatingIncome":36000000.0,"nonOperatingExpenses":8000000.0,"interestExpense":0.0,"ordinaryProfit":269000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":269000000.0,"incomeTaxes":85000000.0,"netIncome":184000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":179000000.0,"comprehensiveIncome":167000000.0,"eps":30.29,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":361000000.0,"depreciationAndCashflowFromOperatingActivities":107000000.0,"cashFlowFromInvestingActivities":-155000000.0,"cashFlowFromFinancialActivities":-49000000.0,"changesInCashAndCashEquivalents":154000000.0,"列1":"q2r","submitDate":"2019\/8\/9","stockCode":3386,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2019\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.786,"cashAndCashEquivalents":null,"assets":8580000000.0,"currentAssets":5658000000.0,"fixedAsset":2922000000.0,"tangibleFixedAssets":714000000.0,"intangibleFixedAssets":215000000.0,"investmentAndOtherAssets":1992000000.0,"liabilities":1354000000.0,"currentLiabilities":809000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":544000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7226000000.0,"capitalStock":6305000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4203000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":442000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":5595000000.0,"costOfSales":3438000000.0,"grossProfit":2157000000.0,"sgaExpenses":1801000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":355000000.0,"nonOperatingIncome":44000000.0,"nonOperatingExpenses":8000000.0,"interestExpense":0.0,"ordinaryProfit":391000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":391000000.0,"incomeTaxes":123000000.0,"netIncome":268000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":259000000.0,"comprehensiveIncome":258000000.0,"eps":43.75,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2019\/11\/8","stockCode":3386,"accountingYear":null,"accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2019\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":133.0,"averageTemporaryStaff":41.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2480800.0,"sharesOwendPercent":0.4184,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1154.32,"equityRatio":0.77,"cashAndCashEquivalents":2416000000.0,"assets":8890000000.0,"currentAssets":5927000000.0,"fixedAsset":2962000000.0,"tangibleFixedAssets":695000000.0,"intangibleFixedAssets":199000000.0,"investmentAndOtherAssets":2068000000.0,"liabilities":1568000000.0,"currentLiabilities":987000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":581000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7321000000.0,"capitalStock":6283000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4181000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":558000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":7590000000.0,"costOfSales":4710000000.0,"grossProfit":2879000000.0,"sgaExpenses":2474000000.0,"salaryAndBenefit":665000000.0,"depreciationAndSGA":null,"RDExpenses":81000000.0,"operatingIncome":405000000.0,"nonOperatingIncome":72000000.0,"nonOperatingExpenses":7000000.0,"interestExpense":0.0,"ordinaryProfit":470000000.0,"extraordinaryGain":null,"extraordinaryLoss":81000000.0,"incomeBeforeTax":388000000.0,"incomeTaxes":142000000.0,"netIncome":246000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":237000000.0,"comprehensiveIncome":353000000.0,"eps":40.14,"dilutedEps":null,"dividendPerShare":null,"per":26.1,"roe":0.035,"cashFlowFromOperatingActivities":549000000.0,"depreciationAndCashflowFromOperatingActivities":207000000.0,"cashFlowFromInvestingActivities":-115000000.0,"cashFlowFromFinancialActivities":-85000000.0,"changesInCashAndCashEquivalents":348000000.0,"列1":"asr","submitDate":"2020\/3\/25","stockCode":3386,"accountingYear":"第37期（自　2019年１月１日　至　2019年12月31日）","accountingYearStart":"2019\/1\/1","accountingYearEnd":"2019\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2020\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.759,"cashAndCashEquivalents":null,"assets":9295000000.0,"currentAssets":6315000000.0,"fixedAsset":2980000000.0,"tangibleFixedAssets":689000000.0,"intangibleFixedAssets":189000000.0,"investmentAndOtherAssets":2101000000.0,"liabilities":1758000000.0,"currentLiabilities":1158000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":600000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7537000000.0,"capitalStock":6469000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4366000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":582000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2420000000.0,"costOfSales":1486000000.0,"grossProfit":934000000.0,"sgaExpenses":586000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":347000000.0,"nonOperatingIncome":8000000.0,"nonOperatingExpenses":0.0,"interestExpense":0.0,"ordinaryProfit":355000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":355000000.0,"incomeTaxes":114000000.0,"netIncome":241000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":232000000.0,"comprehensiveIncome":265000000.0,"eps":39.23,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/5\/13","stockCode":3386,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2020\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2499278.0,"sharesOwendPercent":0.4216,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.779,"cashAndCashEquivalents":3171000000.0,"assets":9304000000.0,"currentAssets":6300000000.0,"fixedAsset":3003000000.0,"tangibleFixedAssets":673000000.0,"intangibleFixedAssets":172000000.0,"investmentAndOtherAssets":2157000000.0,"liabilities":1569000000.0,"currentLiabilities":976000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":593000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7734000000.0,"capitalStock":6687000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4584000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":560000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":3946000000.0,"costOfSales":2416000000.0,"grossProfit":1529000000.0,"sgaExpenses":1098000000.0,"salaryAndBenefit":333000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":431000000.0,"nonOperatingIncome":51000000.0,"nonOperatingExpenses":0.0,"interestExpense":0.0,"ordinaryProfit":482000000.0,"extraordinaryGain":190000000.0,"extraordinaryLoss":null,"incomeBeforeTax":673000000.0,"incomeTaxes":212000000.0,"netIncome":461000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":450000000.0,"comprehensiveIncome":462000000.0,"eps":76.0,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":735000000.0,"depreciationAndCashflowFromOperatingActivities":85000000.0,"cashFlowFromInvestingActivities":70000000.0,"cashFlowFromFinancialActivities":-49000000.0,"changesInCashAndCashEquivalents":755000000.0,"列1":"q2r","submitDate":"2020\/8\/11","stockCode":3386,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2020\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.775,"cashAndCashEquivalents":null,"assets":9422000000.0,"currentAssets":6383000000.0,"fixedAsset":3039000000.0,"tangibleFixedAssets":649000000.0,"intangibleFixedAssets":165000000.0,"investmentAndOtherAssets":2224000000.0,"liabilities":1628000000.0,"currentLiabilities":1057000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":570000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7794000000.0,"capitalStock":6764000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4662000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":533000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":5826000000.0,"costOfSales":3539000000.0,"grossProfit":2286000000.0,"sgaExpenses":1670000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":616000000.0,"nonOperatingIncome":60000000.0,"nonOperatingExpenses":0.0,"interestExpense":0.0,"ordinaryProfit":676000000.0,"extraordinaryGain":190000000.0,"extraordinaryLoss":null,"incomeBeforeTax":867000000.0,"incomeTaxes":272000000.0,"netIncome":594000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":575000000.0,"comprehensiveIncome":569000000.0,"eps":97.05,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/11\/10","stockCode":3386,"accountingYear":null,"accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2020\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":134.0,"averageTemporaryStaff":46.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2473100.0,"sharesOwendPercent":0.4171,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1241.18,"equityRatio":0.763,"cashAndCashEquivalents":3159000000.0,"assets":9640000000.0,"currentAssets":6756000000.0,"fixedAsset":2883000000.0,"tangibleFixedAssets":636000000.0,"intangibleFixedAssets":165000000.0,"investmentAndOtherAssets":2081000000.0,"liabilities":1779000000.0,"currentLiabilities":1226000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":552000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7861000000.0,"capitalStock":6863000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4761000000.0,"treasuryStock":-67000000.0,"valuationAndConversionAdjustments":494000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":8092000000.0,"costOfSales":4940000000.0,"grossProfit":3152000000.0,"sgaExpenses":2399000000.0,"salaryAndBenefit":654000000.0,"depreciationAndSGA":null,"RDExpenses":80000000.0,"operatingIncome":752000000.0,"nonOperatingIncome":71000000.0,"nonOperatingExpenses":6000000.0,"interestExpense":0.0,"ordinaryProfit":817000000.0,"extraordinaryGain":190000000.0,"extraordinaryLoss":null,"incomeBeforeTax":1008000000.0,"incomeTaxes":307000000.0,"netIncome":701000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":674000000.0,"comprehensiveIncome":636000000.0,"eps":113.7,"dilutedEps":null,"dividendPerShare":null,"per":10.8,"roe":0.095,"cashFlowFromOperatingActivities":803000000.0,"depreciationAndCashflowFromOperatingActivities":175000000.0,"cashFlowFromInvestingActivities":42000000.0,"cashFlowFromFinancialActivities":-97000000.0,"changesInCashAndCashEquivalents":743000000.0,"列1":"asr","submitDate":"2021\/3\/24","stockCode":3386,"accountingYear":"第38期（自　2020年１月１日　至　2020年12月31日）","accountingYearStart":"2020\/1\/1","accountingYearEnd":"2020\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2021\/3\/31","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.753,"cashAndCashEquivalents":null,"assets":9933000000.0,"currentAssets":6975000000.0,"fixedAsset":2957000000.0,"tangibleFixedAssets":624000000.0,"intangibleFixedAssets":164000000.0,"investmentAndOtherAssets":2168000000.0,"liabilities":1937000000.0,"currentLiabilities":1327000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":609000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7996000000.0,"capitalStock":6902000000.0,"capital":918000000.0,"capitalSurplus":1251000000.0,"accumulatedEarnings":4940000000.0,"treasuryStock":-207000000.0,"valuationAndConversionAdjustments":575000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":2878000000.0,"costOfSales":1736000000.0,"grossProfit":1142000000.0,"sgaExpenses":593000000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":549000000.0,"nonOperatingIncome":7000000.0,"nonOperatingExpenses":22000000.0,"interestExpense":0.0,"ordinaryProfit":534000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":534000000.0,"incomeTaxes":184000000.0,"netIncome":349000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":333000000.0,"comprehensiveIncome":430000000.0,"eps":56.8,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/5\/12","stockCode":3386,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2021\/6\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2499600.0,"sharesOwendPercent":0.4327,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.778,"cashAndCashEquivalents":3235000000.0,"assets":9635000000.0,"currentAssets":6797000000.0,"fixedAsset":2838000000.0,"tangibleFixedAssets":606000000.0,"intangibleFixedAssets":194000000.0,"investmentAndOtherAssets":2037000000.0,"liabilities":1613000000.0,"currentLiabilities":1015000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":597000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8022000000.0,"capitalStock":7015000000.0,"capital":918000000.0,"capitalSurplus":1252000000.0,"accumulatedEarnings":5097000000.0,"treasuryStock":-251000000.0,"valuationAndConversionAdjustments":483000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":4835000000.0,"costOfSales":2893000000.0,"grossProfit":1942000000.0,"sgaExpenses":1225000000.0,"salaryAndBenefit":348000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":716000000.0,"nonOperatingIncome":49000000.0,"nonOperatingExpenses":14000000.0,"interestExpense":0.0,"ordinaryProfit":752000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":752000000.0,"incomeTaxes":239000000.0,"netIncome":512000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":490000000.0,"comprehensiveIncome":500000000.0,"eps":84.19,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":600000000.0,"depreciationAndCashflowFromOperatingActivities":78000000.0,"cashFlowFromInvestingActivities":-187000000.0,"cashFlowFromFinancialActivities":-343000000.0,"changesInCashAndCashEquivalents":76000000.0,"列1":"q2r","submitDate":"2021\/8\/11","stockCode":3386,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2021\/9\/30","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.786,"cashAndCashEquivalents":null,"assets":9773000000.0,"currentAssets":6983000000.0,"fixedAsset":2789000000.0,"tangibleFixedAssets":593000000.0,"intangibleFixedAssets":197000000.0,"investmentAndOtherAssets":1998000000.0,"liabilities":1570000000.0,"currentLiabilities":915000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":654000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8203000000.0,"capitalStock":7090000000.0,"capital":918000000.0,"capitalSurplus":1258000000.0,"accumulatedEarnings":5153000000.0,"treasuryStock":-239000000.0,"valuationAndConversionAdjustments":586000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":6881000000.0,"costOfSales":4135000000.0,"grossProfit":2745000000.0,"sgaExpenses":1850000000.0,"salaryAndBenefit":524000000.0,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":895000000.0,"nonOperatingIncome":58000000.0,"nonOperatingExpenses":16000000.0,"interestExpense":0.0,"ordinaryProfit":937000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":937000000.0,"incomeTaxes":297000000.0,"netIncome":640000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":615000000.0,"comprehensiveIncome":732000000.0,"eps":105.91,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/11\/10","stockCode":3386,"accountingYear":null,"accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0},{"edinetCode":"E02991","endDate":"2021\/12\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":144.0,"averageTemporaryStaff":51.0,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2648100.0,"sharesOwendPercent":0.4572,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":1344.48,"equityRatio":0.773,"cashAndCashEquivalents":3255000000.0,"assets":10072000000.0,"currentAssets":7310000000.0,"fixedAsset":2761000000.0,"tangibleFixedAssets":599000000.0,"intangibleFixedAssets":182000000.0,"investmentAndOtherAssets":1979000000.0,"liabilities":1752000000.0,"currentLiabilities":1093000000.0,"shorTermDept":20000000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":658000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8319000000.0,"capitalStock":7212000000.0,"capital":918000000.0,"capitalSurplus":1258000000.0,"accumulatedEarnings":5274000000.0,"treasuryStock":-239000000.0,"valuationAndConversionAdjustments":574000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":9231000000.0,"costOfSales":5572000000.0,"grossProfit":3658000000.0,"sgaExpenses":2609000000.0,"salaryAndBenefit":705000000.0,"depreciationAndSGA":null,"RDExpenses":70000000.0,"operatingIncome":1048000000.0,"nonOperatingIncome":71000000.0,"nonOperatingExpenses":20000000.0,"interestExpense":0.0,"ordinaryProfit":1099000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":1099000000.0,"incomeTaxes":330000000.0,"netIncome":768000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":737000000.0,"comprehensiveIncome":848000000.0,"eps":126.94,"dilutedEps":null,"dividendPerShare":null,"per":9.2,"roe":0.097,"cashFlowFromOperatingActivities":648000000.0,"depreciationAndCashflowFromOperatingActivities":166000000.0,"cashFlowFromInvestingActivities":-145000000.0,"cashFlowFromFinancialActivities":-420000000.0,"changesInCashAndCashEquivalents":95000000.0,"列1":"asr","submitDate":"2022\/3\/24","stockCode":3386,"accountingYear":"第39期（自　2021年１月１日　至　2021年12月31日）","accountingYearStart":"2021\/1\/1","accountingYearEnd":"2021\/12\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E02991","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":918,"settlementDate":"2022\/12\/31","submitterName":"コスモ・バイオ株式会社","submitterNameEnglish":"COSMO BIO COMPANY, LIMITED","submitterNameKana":"コスモバイオカブシキガイシャ","location":"江東区東陽二丁目２番２０号","industory":"卸売業","corporateNumber":6010000000000.0}]